Protocol Ledger

NCT04378790 · Phase III · RECRUITING

A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

Interventional Phase III clinical trial protocol NCT04378790 sponsored by Jaeb Center for Health Research in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-12-08 Enrollment: 544 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04378790
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)544 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04378790
Protocol FieldVerified Registry Value
NCT IdentifierNCT04378790
Consolidated Lead SponsorJaeb Center for Health Research
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment544 participants (ESTIMATED)
Registered Start Date2020-12-08
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04378790
Hospital Research SiteLocationSite Profile
University of Alabama at BirminghamBirmingham, ALOpen Hospital Dossier ->
University of ArizonaTucson, AZOpen Hospital Dossier ->
Loma Linda University Medical CenterLoma Linda, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI